BIOHOPE
MTX-cell ARTHRITIS
Biomarkers / Diagnostic
Autoimmune & Inflammation
IVD in clinical validation stage that will help to define the best immunosuppressant combination possible for the selection of first line treatment in a certain patient suffering rheumatoid arthritis.
3Clinical validation,
2Preclinical Validation,
1R+D
Spain